«Once the ovarian cancer becomes drug resistant we can not cure it,» says Rodriguez
a gynecologic oncologist who provides treatment to ovarian cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
Based on a calculation called the «Risk of Ovarian Cancer Algorithm,» women were divided into three groups: those
who should receive another CA125 test one year later (low risk), those
who should receive a repeat CA125 in three months (intermediate risk), and those
who should receive a transvaginal ultrasound and be referred to a
gynecologic oncologist (high risk).
Patients are treated by a multi-disciplinary team that may include medical
oncologists, radiation
oncologists, surgical
oncologists, neuro
oncologists, internal medicine, family practice and radiology; board certified surgeons
who are specialists in reconstructive,
gynecologic, urologic and neurologic surgery; nurses specially trained in cancer treatment and certified to administer chemotherapy, counselors,
who address a full range of psychosocial needs from diagnosis through bereavement; clergy to support all faiths; physical, occupational, speech and nutritional therapists.